Granaticin B

DB17273InvestigationalSmall molecule

Granaticin B: Overview.

Formula / weight: C₂₈H₃₀O₁₂ · 558.536 g/mol (avg)
Also known as: 8,11-ethanofuro(2,3-e)naphtho(2,3-c:6,7-c')dipyran-2,6,13(9h)-trione, 3,3a,5,8,11,13b-hexahydro-7,8,12-trihydroxy-5,9-dimethyl-15-(((2s,5s,6s)-tetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)oxy)-, (3as,5s,8s,9r,11r,13bs,15r)-
Code names: LBS-007 · MM-44326

Resolves to

Compound

Structure

[H][C@]12CC(=O)O[C@@]1([H])C1=C([C@H](C)O2)C(=O)C2=C(C(O)=C3[C@H]4C[C@@H](O[C@H]5CC[C@H](O)[C@H](C)O5)[C@@](O)([C@@H](C)O4)C3=C2O)C1=O

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of Granaticin B, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.